Daguluan, Jhamren G.

HRN: 19-66-76  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2022
CEFUROXIME 750MG (VIAL)
06/18/2022
06/25/2022
IV
150mg
Q8h
Pcap C
Waiting Final Action 
06/22/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/22/2022
06/28/2022
IVTT
125mg
Q6
Pneumonia
Waiting Final Action 
07/07/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/07/2023
07/13/2023
IVTT
124 Mg
OD
Pcap-d
Waiting Final Action 
07/07/2023
CEFTRIAXONE 1G (VIAL)
07/07/2023
07/13/2023
IVTT
830
OD
Pcap-D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: